Decreased striatal dopamine receptor binding in primary focal dystonia: a D2 or D3 defect? - Wikidata - awgldk - TriplyDB

Decreased striatal dopamine receptor binding in primary focal dystonia: a D2 or D3 defect?

Decreased striatal dopamine receptor binding in primary focal dystonia: a D2 or D3 defect?

http://www.wikidata.org/entity/Q34512173

about

The role of dopamine and dopaminergic pathways in dystonia: insights from neuroimaging Research Priorities in Limb and Task-Specific Dystonias Striatal dopamine D1-like receptor binding is unchanged in primary focal dystonia.Spatial reorganization of putaminal dopamine D2-like receptors in cranial and hand dystonia A new treatment for focal dystonias: incobotulinumtoxinA (Xeomin®), a botulinum neurotoxin type A free from complexing proteins Insulin, Central Dopamine D2 Receptors, and Monetary Reward Discounting in Obesity.Emotional Eating Phenotype is Associated with Central Dopamine D2 Receptor Binding Independent of Body Mass Index Characterization of extrastriatal D2 in vivo specific binding of [¹⁸F](N-methyl)benperidol using PET.Striatal microcircuitry and movement disorders Mouse models of neurodevelopmental disease of the basal ganglia and associated circuits.Altered brain activation in a reversal learning task unmasks adaptive changes in cognitive control in writer's cramp Imaging studies in focal dystonias: a systems level approach to studying a systems level disorder The focal dystonias: current views and challenges for future research A comparison of D2 receptor specific binding in obese and normal-weight individuals using PET with (N-[(11)C]methyl)benperidol.Striatal dopaminergic dysfunction at rest and during task performance in writer's cramp.Absorbed radiation dosimetry of the D3-specific PET radioligand [18F]FluorTriopride estimated using rodent and nonhuman primate.Prediction of striatal D2 receptor binding by DRD2/ANKK1 TaqIA allele status.Positron emission tomography imaging of dopamine D2 receptors using a highly selective radiolabeled D2 receptor partial agonist.Endogenous dopamine (DA) competes with the binding of a radiolabeled D₃ receptor partial agonist in vivo: a positron emission tomography study Loss of inhibition in sensorimotor networks in focal hand dystonia.Challenges in the development of dopamine D2- and D3-selective radiotracers for PET imaging studies.

P2860

Q26865047-6CE976AE-3069-4E19-80FF-9E5173940B9A Q30572682-80184B6E-3252-4317-8FF6-C784F4AD5BFF Q33863502-E2864B34-89C8-485C-A782-B819323ABBB7 Q35092703-7ECF5EEE-E396-4C4F-BC7F-4BB8F57972F9 Q35681898-E3C1AD57-2238-4845-A111-C80C2A15B674 Q35698391-F3C88190-5894-40A5-A93F-03C994246A03 Q35727823-36D3BE5C-BA58-4037-A877-8C6DA4689690 Q36075795-77DE91FD-72BF-4650-95E7-BF2BC5EA421B Q36203205-A2881CA4-8510-4290-B49C-70C9871CDBCA Q36266325-82BCA2D0-E15F-4095-9B31-B9E7EF1B839E Q36346470-45432741-C73F-49A9-9535-63588255105D Q36634143-19C2CEFE-62B7-4130-B48A-1D4DE4814601 Q37070290-9D5A9823-7071-40A9-9155-481CDAF312B4 Q37185341-E89A94C1-EC83-42AF-99AD-D613D3CA34EA Q37383467-715672B9-2147-45E3-98E9-244DA859953D Q37568555-5B2080DA-94EE-417D-8668-937694C2550C Q41657879-365D3DBE-3A1A-4875-869A-6AACB4774FC0 Q41998180-989CEE92-6208-4C7B-A229-530D373EAA30 Q42745808-3FDF1051-9140-45BB-8561-C34A8157C9E5 Q46134256-8AE2B6C8-3656-4443-AE2D-BE9834107FE9 Q48149406-72505923-D52C-4FC4-A2E3-EB50EACCA0E6

P2860

Decreased striatal dopamine receptor binding in primary focal dystonia: a D2 or D3 defect?

http://www.wikidata.org/entity/Q34512173

description

2010 nî lūn-bûn

@nan

2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Decreased striatal dopamine re ...... l dystonia: a D2 or D3 defect?

@ast

Decreased striatal dopamine re ...... l dystonia: a D2 or D3 defect?

@en

Decreased striatal dopamine re ...... l dystonia: a D2 or D3 defect?

@nl

type

label

Decreased striatal dopamine re ...... l dystonia: a D2 or D3 defect?

@ast

Decreased striatal dopamine re ...... l dystonia: a D2 or D3 defect?

@en

Decreased striatal dopamine re ...... l dystonia: a D2 or D3 defect?

@nl

prefLabel

Decreased striatal dopamine re ...... l dystonia: a D2 or D3 defect?

@ast

Decreased striatal dopamine re ...... l dystonia: a D2 or D3 defect?

@en

Decreased striatal dopamine re ...... l dystonia: a D2 or D3 defect?

@nl

P1433

Q34512173-D0BE69CA-77F3-4CD9-A949-A233B2816385

P1476

Q34512173-7944C170-278F-4277-9297-9AAFD80A2727

P2093

Q34512173-818AD487-A5CD-4A64-B094-842493B08FD2

Q34512173-9535B9B0-A357-4791-AFC3-CD5252C801A2

Q34512173-96C66BF3-0328-422E-B42E-9E267091252E

Q34512173-ACDBFFAD-E074-497C-9E55-4B36F1BC044D

Q34512173-AEF25ED2-4620-4730-990D-E517301EFAA6

P2860

Q34512173-028F16AC-FDCB-427D-96EC-0B6F826D5829

Q34512173-04D99BCE-14F2-4BBA-A1F3-9C579ABB74A8

Q34512173-0847B40C-67F2-4DDE-9211-294F0B6BA5FD

Q34512173-0C44A970-4B30-47A5-AD89-69960C50B56B

Q34512173-19DAC01C-868D-4A46-80F3-CF4DF57C5920

Q34512173-1F01B597-4D99-49CB-9C06-802C75561657

Q34512173-2489B57A-00C3-4634-8E10-9088FC87A2AB

Q34512173-254792D1-F49B-43B4-80FE-1C5CEBD80B87

Q34512173-27D01EA3-9D55-4123-B8C0-FB03B0FDE881

Q34512173-2ABF271D-CE40-42A7-82C9-197E29C33E24

P304

Q34512173-F087BE7B-7ED8-439E-807F-C6F6055F38B0

P31

Q34512173-3A17DB67-2356-4E0A-91B4-054C98814477

P356

Q34512173-D58A5F17-90B6-42AE-9440-FEB0008D253B

P407

Q34512173-CA848B1F-7AB5-4543-A123-ADDE8D8804C0

P433

Q34512173-52EB5B5D-5C77-473D-9A3F-083EA0D288F2

P478

Q34512173-0EE586F1-0855-47E1-98A4-96187638FA26

P50

Q34512173-089C75B0-B356-48F0-9C75-5615ACD30329

Q34512173-99F43CB6-51BA-48D3-9CBC-5697A1CE9F25

P577

Q34512173-06F8E694-A17C-49AE-AFBC-62B2AC02DAF4

P5875

Q34512173-B876C96F-6797-4972-9500-8ED7453D1ED5

P698

Q34512173-1C7C99A5-23E4-42F0-AB13-280380B9585B

P921

Q34512173-4b3d3af0-ab21-41aa-8b53-3956606ee43e

Q34512173-DA61E265-1AB9-4551-836E-A28B478CA9BD

P932

Q34512173-93982C95-8CAF-4E63-B8E6-EEDC8CC8FDEA

P356

P1433

Movement Disorders

P1476

Decreased striatal dopamine re ...... l dystonia: a D2 or D3 defect?

@en

P2093

Michelle Taylor

http://www.w3.org/2001/XMLSchema#string

Morvarid Karimi

http://www.w3.org/2001/XMLSchema#string

Robert H Mach

http://www.w3.org/2001/XMLSchema#string

Robert R Luedtke

http://www.w3.org/2001/XMLSchema#string

Stephen M Moerlein

http://www.w3.org/2001/XMLSchema#string

P2860

A rating scale for depression

Identification of dopamine D1-D3 receptor heteromers. Indications for a role of synergistic D1-D3 receptor interactions in the striatum

“Mini-mental state”

Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction

Parallel Organization of Functionally Segregated Circuits Linking Basal Ganglia and Cortex

D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons

Functional architecture of basal ganglia circuits: neural substrates of parallel processing

Short intracortical and surround inhibition are selectively reduced during movement initiation in focal hand dystonia.

The dopamine motor system.

Dichotomous dopaminergic control of striatal synaptic plasticity.

P304

100-106

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/MDS.23401

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

26

http://www.w3.org/2001/XMLSchema#string

P50

Joel S Perlmutter

P577

2010-10-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

47500962

http://www.w3.org/2001/XMLSchema#string

P698

20960437

http://www.w3.org/2001/XMLSchema#string

P921

corpus striatum

P932

3025272

http://www.w3.org/2001/XMLSchema#string